← Back to Search

Endoluminal Vascular Device

Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal) (l Trial)

N/A
Waitlist Available
Led By Edward B Diethrich, M.D.
Research Sponsored by Arizona Heart Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of the study is to evaluate the TALENT endoluminal stent-graft system in patients with abdominal aortic aneurysms. The TALENT endoluminal stent-graft system is a flexible, implantable endoluminal vascular device preloaded in a placement system that is used to exclude abdominal aortic aneurysms.

Eligible Conditions
  • Abdominal Aortic Aneurysm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Arizona Heart InstituteLead Sponsor
7 Previous Clinical Trials
825 Total Patients Enrolled
Edward B Diethrich, M.D.Principal InvestigatorArizona Heart Institute
6 Previous Clinical Trials
695 Total Patients Enrolled
~3 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top